Seven Eight Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Seven Eight Capital's LLY Position: Q4 2024 in Review
Seven Eight Capital sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 5,827 shares — an estimated $5.16M sold.
Seven Eight Capital first reported a position in LLY in Q2 2014 and held it in 15 quarters. The position peaked at $6.89M in Q4 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Seven Eight Capital reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
- Seven Eight Capital sold 5,827 Eli Lilly shares in Q4 2024, an estimated $5.16M.
- Seven Eight Capital first reported a position in Eli Lilly in Q2 2014 and held it in 15 quarters.
- Seven Eight Capital's Eli Lilly position peaked at $6.89M in Q4 2023.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Seven Eight Capital's 13F filing for Q4 2024.